sequence id,run,hcv_wg_pipeline,pipeline_version,sample id,sample date,initial genotype,genotype,subtype,Genotyping CORE,Genotyping E1,Genotyping E2,Genotyping P7,Genotyping NS2,Genotyping NS3,Genotyping NS4A,Genotyping NS4B,Genotyping NS5A,Genotyping NS5B,patient id,treatment id,regime,treatment date,drug id,drug manufacturer,therapy class,city,country of birth,date of birth,diagnosis date,ethnicity,nationality,gender,hiv status
H210920588-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210920588,20-Mar-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,118,,,,,,,-,-,02-Nov-2067,28-Aug-1992,White,Others,Male,Yes
H210700034-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210700034,23-Mar-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,151,,,,,,,-,Ghana,14-Aug-1977,21-Jan-2005,White,British,Female,Yes
H210880181-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880181,29-Sep-2020,-,Check genotyping results by genes: NULL 1a,-,,,,,,1a,1a,,1a,1a,152,,,,,,,Oxford,England,13-Mar-1981,04-Mar-1998,White,British,Female,Yes
H210880650-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880650,08-Jun-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,153,,,,,,,London,Brazil,05-Sep-1989,08-Jan-1991,Not Stated,Brazilian,Other,Yes
H210880653-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880653,02-Oct-2020,-,Check genotyping results by genes: 1a 1,-,1a,1,1a,1a,1a,1a,1a,1a,1a,1a,154,,,,,,,-,Portugal,23-Feb-1971,03-Sep-1991,White,Portuguese,Male,Yes
H210880654-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880654,09-Feb-2020,-,Check genotyping results by genes:,-,,,,,,,,,,,155,,,,,,,-,England,04-Apr-1972,05-Feb-1998,Other/Mixed,British,Other,No
H210880664-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880664,25-May-2020,1a,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,156,,,,,,,-,China,23-Mar-2061,30-Oct-1988,White,Chinese,Female,No
H210880665-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880665,31-Jan-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,157,,,,,,,-,USA,14-Jul-1979,09-Oct-1994,White,British,Unknown,Yes
H210880666-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210880666,19-Sep-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,158,,,,,,,-,Russia,19-Jul-2069,25-Apr-1988,Asian,Russian,Male,No
H210900534-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900534,14-Feb-2020,Not available,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,159,,,,,,,-,Korea,31-Oct-2059,29-May-1989,Other/Mixed,Korean,Unknown,Yes
H210900535-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900535,30-Jan-2021,Not available,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,160,27.0,-,05-May-2019,beclabuvir,BMS,NS5B non-nucleotide polymerase inhibitor,London,Ireland,11-Nov-1989,14-Dec-2000,White,Irish,Male,Yes
H210900535-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900535,30-Jan-2021,Not available,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,160,31.0,2 tablets per day,07-Jan-2011,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,London,Ireland,11-Nov-1989,14-Dec-2000,White,Irish,Male,Yes
H210900536-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900536,13-Mar-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,161,32.0,1 tablet per day,05-May-2019,dasabuvir,-,-,-,Ireland,17-Nov-1971,27-Dec-1995,White,Irish,Female,Yes
H210900536-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900536,13-Mar-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,161,33.0,1 tablet per day,05-May-2019,ledipasvir,Gilead,NS5A inhibitor,-,Ireland,17-Nov-1971,27-Dec-1995,White,Irish,Female,Yes
H210900536-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900536,13-Mar-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,161,28.0,-,08-Sep-2020,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,-,Ireland,17-Nov-1971,27-Dec-1995,White,Irish,Female,Yes
H210900537-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900537,12-May-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,162,,,,,,,-,Spain,31-May-2065,01-Mar-1988,Not Stated,Spanish,Female,Yes
H210900538-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900538,24-Apr-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,163,29.0,1 tablet per day,07-Jan-2011,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,-,France,12-Mar-2040,20-Oct-2003,Not Stated,French,-,-
H210900539-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210900539,13-Nov-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,164,,,,,,,-,Kenya,10-May-1981,20-May-2003,White,Kenyan,Unknown,-
H210920145-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210920145,17-Jan-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,165,,,,,,,-,France,01-Sep-2057,10-Oct-1997,White,Italian,Male,No
H210920146-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210920146,16-Feb-2020,-,2,b,2b,2b,2b,2b,2b,2b,2b,2b,2b,2b,166,,,,,,,London,Russia,30-Sep-2045,25-Apr-1993,White,Russian,Male,No
H210940531-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210940531,09-Jan-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,168,,,,,,,-,Scotland,08-Oct-1973,13-Dec-1995,-,British,Female,-
H210960137-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960137,05-Nov-2019,3a & 1a (dual infection),Check genotyping results by genes: 1 1a,-,1,1a,1a,1a,1a,1a,1a,1a,1a,1a,169,,,,,,,-,Scotland,21-Jan-2064,18-Nov-2004,Asian,British,Unknown,No
H210960524-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960524,18-Feb-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,170,,,,,,,London,-,09-Jul-1979,11-Jan-1991,White,British,Female,Yes
H210960527-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960527,03-Feb-2021,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,171,,,,,,,London,Russia,27-Feb-2047,04-Mar-1990,Black African,Russian,Other,Yes
H210960908-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960908,25-Mar-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,172,,,,,,,Manchester,England,18-May-1974,13-May-2004,Other/Mixed,British,Unknown,Yes
H210960909-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960909,15-Oct-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,173,,,,,,,London,England,08-Apr-2048,25-Mar-1990,Asian,British,Male,Yes
H210960910-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960910,24-Jul-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,174,,,,,,,Salisbury,England,09-Sep-2060,28-Apr-1990,Asian,British,Male,Yes
H210960911-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210960911,24-Mar-2021,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,175,,,,,,,-,England,28-May-1974,25-May-2005,White,British,Other,Yes
H210980721-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980721,01-Oct-2020,-,Check genotyping results by genes: 2k 2 1b,-,2k,2k,2k,2k,2,1b,1b,1b,1b,1b,176,,,,,,,-,Scotland,25-Feb-1976,11-Jul-1998,White,British,Other,No
H210980722-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980722,04-Oct-2020,-,Check genotyping results by genes: 1a 1,-,1a,1a,1a,1a,1a,1a,1,1a,1a,1a,177,,,,,,,-,Gibraltar,17-Jul-1986,25-Mar-1990,Asian,British,Other,No
H210980723-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980723,12-Jun-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,178,,,,,,,London,Cuba,06-Nov-1978,25-Dec-2003,White,Cuban,Male,Yes
H210980724-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980724,07-Jul-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,179,,,,,,,-,Ghana,06-Jun-2043,08-Jul-1989,White,British,Male,No
H210980725-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980725,07-Oct-2019,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,180,34.0,-,08-Sep-2020,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,London,England,22-Apr-2050,26-Dec-2002,White,British,Unknown,Yes
H210980726-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980726,07-Aug-2020,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,181,,,,,,,-,Brazil,18-Nov-1981,02-Nov-2003,Other/Mixed,Brazilian,Female,Yes
H210980727-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980727,14-Dec-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,182,,,,,,,London,Portugal,30-Jul-1972,23-Jul-1996,White,Portuguese,Other,Yes
H210980728-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H210980728,13-Jan-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,183,,,,,,,-,England,24-Mar-2050,08-Oct-1988,Black African,British,Female,Yes
H211000392-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211000392,28-Jan-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,184,,,,,,,London,China,22-Apr-2050,25-Sep-1990,White,Chinese,Other,Yes
H211040783-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211040783,11-Mar-2021,-,Check genotyping results by genes: NULL 3a,-,,,,3a,,,3a,3a,,,185,,,,,,,-,USA,21-Sep-2066,01-May-1994,Black Caribbean,British,Other,Yes
H211040784-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211040784,10-Nov-2019,1a,Check genotyping results by genes: 2k 2 1b,-,2k,2k,2k,2k,2,1b,1b,1b,1b,1b,186,,,,,,,-,Russia,16-Mar-1988,29-Nov-1996,White,Russian,Female,No
H211060465-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060465,28-Oct-2019,-,Check genotyping results by genes: NULL 3a,-,,,,,,,,3a,,,187,35.0,-,07-Jan-2011,paritaprevir,AbbVie,NS3A/4A protease inhibitor,-,Korea,30-May-1973,13-Apr-2005,White,Korean,Unknown,No
H211060466-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060466,03-Mar-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,188,58.0,-,05-Jul-2019,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor,-,Ireland,10-Mar-2062,14-Jul-1996,White,Irish,Female,Yes
H211060466-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060466,03-Mar-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,188,57.0,-,05-Jun-2019,sofosbuvir,Gilead,NS5B nucleotide polymerase inhibitor,-,Ireland,10-Mar-2062,14-Jul-1996,White,Irish,Female,Yes
H211060466-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060466,03-Mar-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,188,59.0,2 tablets per day,08-Aug-2020,dasabuvir,-,-,-,Ireland,10-Mar-2062,14-Jul-1996,White,Irish,Female,Yes
H211060474-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060474,21-May-2019,-,Check genotyping results by genes: 1c 1,-,1c,1c,1,1,1,1,1,1c,1c,1c,189,36.0,-,05-Feb-1988,ritonavir,AbbVie,NS5A inhibitor,London,Ireland,19-Mar-1988,21-Mar-2005,White,Irish,Female,No
H211060475-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060475,09-Apr-2019,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,190,60.0,1 tablet per day,30-Jun-2011,simeprevir,Janssen,NS3A/4A protease inhibitor,London,Spain,23-Jun-2050,04-Oct-2003,Black Caribbean,Spanish,Unknown,Yes
H211060708-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211060708,08-Feb-2020,-,1,a,1a,1a,1a,1a,1a,1a,1a,1a,1a,1a,191,,,,,,,London,France,16-May-2065,22-Feb-2005,White,French,Male,Yes
H211080571-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211080571,13-Feb-2021,-,3,a,3a,3a,3a,3a,3a,3a,3a,3a,3a,3a,192,,,,,,,Cardiff,Kenya,03-Jun-2042,14-Jan-1993,Black African,Kenyan,Other,Yes
H211080572-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211080572,27-Jan-2020,-,1,b,1b,1b,1b,1b,1b,1b,1b,1b,1b,1b,193,,,,,,,Brighton,Scotland,21-Mar-2056,14-Aug-2002,-,British,Female,Yes
H211080573-1_NGS95,NGS95,PHE HCV bioinformatics pipeline,version 1.0,H211080573,21-Apr-2019,-,4,d,4d,4d,4d,4d,4d,4d,4d,4d,4d,4d,194,61.0,2 tablets per day,30-Jun-2011,ledipasvir,Gilead,NS5A inhibitor,Belfast,Gibraltar,20-Jul-2060,01-Feb-1998,Other/Mixed,British,Male,Yes
